PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Year: 2013
Type: article
Source: Current Pharmaceutical Design
Institution: Medical University of Lodz
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Sanofi, Regeneron Pharmaceuticals
OpenAlex ID: W2172156812
